3-(((5-Methylthiazol-2-yl)methyl)amino)propan-1-ol dihydrochloride

Catalog No.: 
ACVRFW365
CAS No.: 
1332531-06-2
Molecular Formula: 
C8H16Cl2N2OS
Molecular Weight: 
259.20
3-(((5-Methylthiazol-2-yl)methyl)amino)propan-1-ol dihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$143.00InquiryInquiry
1g97%$449.00InquiryInquiry
5g97%$2200.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(((5-Methylthiazol-2-yl)methyl)amino)propan-1-ol dihydrochloride
IUPAC Name3-(((5-methylthiazol-2-yl)methyl)amino)propan-1-ol dihydrochloride
MDL No.MFCD18071318
Molecular FormulaC8H16Cl2N2OS
Molecular Weight259.20
SMILESOCCCNCC1=NC=C(C)S1.[H]Cl.[H]Cl
InChI KeyHLBJEDLVFSZNSK-UHFFFAOYSA-N
CAS No.1332531-06-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACVRFW365 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUZOW482 route compound structure diagram
    ACUZOW48213838-78-3In Stock
  2. Plus
  3. ACAIZV137 route compound structure diagram
    ACAIZV13714302-46-6In Stock
  4. Then
  5. ACVRFW365 route product structure diagram
    ACVRFW3651332531-06-2
Inquiry

2. ACVRFW365 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNSRA689 route compound structure diagram
    ACNSRA689202932-04-5In Stock
  2. Plus
  3. ACAIZV137 route compound structure diagram
    ACAIZV13714302-46-6In Stock
  4. Then
  5. ACVRFW365 route product structure diagram
    ACVRFW3651332531-06-2
Inquiry

3. ACVRFW365 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVRFW365 route product structure diagram
    ACVRFW3651332531-06-2
Inquiry

Comments (0)